Coadministration of encorafenib with sensitive CYP3A4 substrates may possibly bring about amplified toxicity or diminished efficacy of those agents. hydrocortisone will decrease the level or effect of diazepam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.